Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy.
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by an asymmetrically hypertrophied left ventricle and is regarded as a disease of cardiac muscle. METHODS AND RESULTS: To assess the possibility that the mitral valve itself may be involved in the disease process, we studied mitral valves from 94 patients with HCM and 45 normal control subjects. The area of the mitral leaflets was increased in patients with HCM compared with control subjects (12.9 +/- 3.7 versus 8.7 +/- 2.0 cm2; p less than 0.001). For the overall group of patients, this increase was largely caused by an increase in anterior leaflet length (2.2 +/- 0.5 cm for HCM versus 1.8 +/- 0.3 cm for control subjects; p less than 0.001), because circumference did not differ between the two groups. Mitral leaflet area was increased (greater than or equal to 12.0 cm2) in 55 (58%) of the 94 valves. In 12 of these 55 valves, both the anterior and posterior leaflets were enlarged; the other 43 valves had asymmetrical or segmental enlargement of either the anterior leaflet (36 patients) or a portion of posterior leaflet (seven patients). In addition, nine patients had a congenital malformation of the mitral apparatus in which one or both papillary muscles inserted directly into anterior mitral leaflet (mitral valve area was normal in seven of the nine). CONCLUSIONS: Sixty-two (66%) of 94 mitral valves had a constellation of structural malformations, including increased leaflet area and elongation of the leaflets or anomalous papillary muscle insertion directly into anterior mitral leaflet. These findings expand the morphological definition of HCM by demonstrating that the disease process is not confined to cardiac muscle but rather many patients also have structural abnormalities of the mitral valve that are unlikely to be acquired or secondary to mechanical factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS
Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,081
Maron, B. J., Bonow, R. O., Cannon, R. O., Leon, M. B., & Epstein, S. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161305 · Cited by 896
Self-citationHypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 823
Maron, B. J., Gottdiener, J. S., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90068-0 · Cited by 607
Self-citationMapping a Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14q1
Jarcho, J. A., McKenna, W., Pare, J. A. P., Solomon, S. D., Holcombe, R. F., Dickie, S., Levi, T., Donis-Keller, H., Seidman, J. G., & Seidman, C. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212005 · Cited by 540
Hypertrophie cardiomyopathy: A discussion of nomenclature
Maron, B. J., & Epstein, S. E. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90160-7 · Cited by 444
Self-citationDavies, M. J., Moore, B. P., & Braimbridge, M. V. (1978) · Heart · doi:10.1136/hrt.40.5.468 · Cited by 358
Shapiro, L. M., & McKenna, W. J. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80269-1 · Cited by 325
Jiang, L., Levine, R. A., King, M. E., & Weyman, A. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90701-0 · Cited by 244
Cited by
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Self-citationGersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationHypertrophic Cardiomyopathy: The Therapeutic Role of Calcium Antagonists
(1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,756
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
Self-citationMaron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
Self-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationMaron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
Self-citationGersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 818
Self-citationHypertrophic Cardiomyopathy: Clinical Spectrum and Treatment
Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 778
Maron, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00479-2 · Cited by 698
Self-citationElliott, P., & McKenna, W. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16358-7 · Cited by 498
Maron, M. S., Olivotto, I., Harrigan, C., Appelbaum, E., Gibson, C. M., Lesser, J. R., Haas, T. S., Udelson, J. E., Manning, W. J., & Maron, B. J. (2011) · Circulation · doi:10.1161/circulationaha.110.985812 · Cited by 451
Self-citationShirani, J., Pick, R., Roberts, W. C., & Maron, B. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00492-1 · Cited by 408
Self-citationMitral valve disease—morphology and mechanisms
Levine, R. A., Hagége, A. A., Judge, D. P., Padala, M., Dal-Bianco, J. P., Aikawa, E., Beaudoin, J., Bischoff, J., Bouatia-Naji, N., Bruneval, P., et al. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.161 · Cited by 386
Maron, B. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01282-8 · Cited by 370
Self-citationNagueh, S. F., Bierig, S. M., Budoff, M. J., Desai, M., Dilsizian, V., Eidem, B., Goldstein, S. A., Hung, J., Maron, M. S., Ommen, S. R., et al. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.03.006 · Cited by 347
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 322
Self-citationDelling, F. N., & Vasan, R. S. (2014) · Circulation · doi:10.1161/circulationaha.113.006702 · Cited by 315
Sherrid, M. V., Gunsburg, D. Z., Moldenhauer, S., & Pearle, G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00830-5 · Cited by 297
Cecchi, F., Olivotto, I., Montereggi, A., Santoro, G., Dolara, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00353-3 · Cited by 296
Self-citationGersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.825 · Cited by 279
Self-citationThe Mitral Valve in Obstructive Hypertrophic Cardiomyopathy
Sherrid, M. V., Balaram, S., Kim, B., Axel, L., & Swistel, D. G. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.071 · Cited by 276
The pathology of hypertrophic cardiomyopathy
Hughes, S. E. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01835.x · Cited by 264
Marino, B., Digilio, M. C., Toscano, A., Giannotti, A., & Dallapiccola, B. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70088-0 · Cited by 258
Maron, B. J., Maron, M. S., Wigle, E. D., & Braunwald, E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.069 · Cited by 257
Self-citationMitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy
Hong, J. H., Schaff, H. V., Nishimura, R. A., Abel, M. D., Dearani, J. A., Li, Z., & Ommen, S. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.735 · Cited by 191
Metadata
- Authors
- Klues, H. G., Maron, B. J., Dollar, A. L., & Roberts, W. C.
- Venue
- Circulation
- Published
- 1992-05
- Volume
- 85
- Issue
- 5
- Pages
- 1651-1660
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2083472574
- Cited by
- 364
- References
- 22
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.